Found 7 matching trials
Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer PHASE2 RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Show More Location
Barbara Ann Karmanos Cancer Institute
Learn More & Join Trial
Pembro and HER2Bi-Armed Activated T Cells in Treating Patients With Metastatic Castration Resistant Prostate Cancer PHASE2 This phase II trial studies how well pembrolizumab and HER2Bi-armed activat...
Show More Location
Wayne State University/Karmanos Cancer Institute
Learn More & Join Trial
Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery PHASE2 RATIONALE: Neoadjuvant chemotherapy for women with stage II-III Her negativ...
Show More Location
Barbara Ann Karmanos Cancer Institute
Learn More & Join Trial
Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent PHASE1 This phase I trial studies the side effects and best dose of activated T-ce...
Show More Location
Multiple Locations
Learn More & Join Trial
BATs in Patients With Breast Cancer and Leptomeningeal Metastases PHASE1 This study uses bi-specific antibody (HER2Bi) armed activated T-cells (HER2...
Show More Location
University of Virginia
Learn More & Join Trial
T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System PHASE1 This phase I trial is to investigate the safety and the possible side effec...
Show More Location
Multiple Locations
Learn More & Join Trial
Her2-BATS and Pembrolizumab in Metastatic Breast Cancer PHASE1 This proposal uses HER2Bi armed activated T-cells (HER2 BATs) to target bre...
Show More Status
Active Not Recruiting
Learn More & Join Trial